Baxter Oncology GmbH manufactures and distributes pharmaceutical products, focusing on standard oncology medications such as Endoxan, Holoxan, and Uromitexan. The company also engages in significant contract manufacturing for third parties at its facilities in Halle/Westfalen and Bielefeld. As part of the Baxter Group, the company is subject to a control and profit transfer agreement with Baxter Deutschland Holding GmbH. Business activities are managed globally by the Baxter Group, with the company operating as a specialized production and distribution unit.
die Herstellung, der Vertrieb, Export und Import von sowie der Handel mit pharmazeutischen Erzeugnissen sowie artverwandten Artikeln.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Gütersloh Local Court, HRB 6882 (as of 21 October 2026)
Source: German Commercial Register (Handelsregister) Gütersloh Local Court, HRB 6882 (as of 21 October 2026)
Source: German Commercial Register (Handelsregister) Gütersloh Local Court, HRB 6882 (as of 21 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Gütersloh Local Court, HRB 6882 (as of 21 October 2026)
Boehringer Ingelheim Vetmedica Gesellschaft mit beschränkter Haftung
Ingelheim am Rhein · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
EMRA-MED Arzneimittel GmbH
Trittau · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
A. Nattermann & Cie. Gesellschaft mit beschränkter Haftung
Frankfurt am Main · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view funding data
Last Round
€12.8M
Series B · Mar 2025
Total
4
Rounds
7
Investors
